Latest Company News

A fully synthetic, modular platform built for precision, flexibility and impact

Pencil Biosciences is developing a fully synthetic gene modulation and editing platform that will have…

Pencil Biosciences has secured £5.6m in seed financing for its gene modulation technology that has…

Pencil Biosciences awarded Innovate UK Investor Partnership grant Pencil Biosciences, a UK-based biotech company, announces…